Evidence map›Paper›PMID 32274387›Full record

ArticleFrontiers in molecular biosciences2020

Comparative Molecular Dynamics Simulations Provide Insight Into Antibiotic Interactions: A Case Study Using the Enzyme L,L-Diaminopimelate Aminotransferase (DapL).

Lily E Adams, Patrick Rynkiewicz, Gregory A Babbitt, Jamie S Mortensen, Rachel A North, Renwick C J Dobson, André O Hudson

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Lily E AdamsThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.
Patrick RynkiewiczThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.
Gregory A BabbittThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.
Jamie S MortensenDepartment of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, United States.
Rachel A NorthBiomolecular Interaction Centre and School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.
Renwick C J DobsonBiomolecular Interaction Centre and School of Biological Sciences, University of Canterbury, Christchurch, New Zealand.
André O HudsonThomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, NY, United States.
Rochester Institute of Technology · USUniversity of Canterbury · NZ

Funding

Genetic and structural analysis of L,L-diaminopimelate aminotransferase (DapL): An attractive target for the development of narrow-spectrum antibioticsR15GM120653 · NIGMS · ROCHESTER INSTITUTE OF TECHNOLOGY · PI HUDSON, ANDRE O · 2016 to 2017
$468k
NIGMS NIH HHS R15 GM120653
6 · The paper itself

Abstract

The L,L-diaminopimelate aminotransferase (DapL) pathway, a recently discovered variant of the lysine biosynthetic pathway, is an attractive pipeline to identify targets for the development of novel antibiotic compounds. DapL is a homodimer that catalyzes the conversion of tetrahydrodipicolinate to L,L-diaminopimelate in a single transamination reaction. The penultimate and ultimate products of the lysine biosynthesis pathway,

Indexed as

antibioticsdiaminopimelateligand bindingL,L-diaminopimelate aminotransferaseL-lysinemolecular dynamicspeptidoglycan

Identifiers

PMID32274387
PMCPMC7113581
OpenAlexW3013966774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.